Creative Biolabs Expands Single-Cell and Multi-Omics Services to Accelerate Biomedical Research

Creative Biolabs has announced a significant expansion of its single-cell multi-omics and RNA sequencing solutions, a move that promises to accelerate biomedical discovery by enabling researchers to profile individual cells with unprecedented resolution. The upgraded suite, designed to meet the growing demand for high-resolution cellular profiling, now offers end-to-end services that span from single-cell transcriptome profiling to integrated multimodal and multi-omics workflows. This development matters because it directly addresses a critical bottleneck in modern life science research: the need to understand cellular heterogeneity in complex tissues, which is essential for identifying rare cell subpopulations, characterizing tumor microenvironments, and tracing cell lineage trajectories.

Central to the expansion is the provision of robust, high-throughput single-cell RNA sequencing services that deliver high sensitivity and coverage across thousands of individual cells. These services are crucial for researchers transitioning from bulk tissue profiling to single-cell resolution, as they enable the capture of high-resolution transcriptomic insights from diverse fresh biological specimens. The ability to analyze thousands of cells individually opens new avenues for understanding disease mechanisms at the cellular level, which can inform the development of more precise therapeutic strategies.

Addressing a long-standing challenge in the laboratory, Creative Biolabs has also introduced specialized single-nucleus RNA sequencing (snRNA-seq) capabilities. For tissues where single-cell dissociation is prone to cell damage, dissociation-induced stress responses, or selective loss of fragile cell types—such as human brain, myocardium, or flash-frozen clinical biopsies—the company provides an optimized single-cell nuclei RNA sequencing service. By isolating intact nuclei, this approach bypasses harsh enzymatic dissociation while minimizing dissociation-related artifacts and retaining informative nuclear RNA profiles. This innovation dramatically expands the scope of clinical translational research, allowing scientists to analyze archival and difficult-to-process samples that were previously inaccessible.

Recognizing that cellular identity is orchestrated across multiple regulatory layers, Creative Biolabs goes beyond single-dimensional analysis by advancing its high-throughput single-cell multi-omics service. This integrated platform permits the simultaneous interrogation of genomic variations, epigenomic landscapes (e.g., chromatin accessibility), cell surface proteomics (CITE-seq), and transcriptomes within identical single cells. By directly linking epigenetic regulation and genomic alterations to gene expression readouts, the service enables researchers to construct multi-dimensional cellular atlases and uncover novel therapeutic targets with unprecedented biological clarity. This capability is particularly important for precision medicine, where understanding the interplay between different molecular layers can reveal new biomarkers and drug targets.

"Understanding biology at single-cell and single-nucleus resolution is no longer a luxury—it is fundamental to precision medicine and biomarker discovery," said a senior scientist at Creative Biolabs. "Our goal is to provide researchers with a seamless, modular analytical ecosystem that transforms difficult biological samples into reliable, high-dimensional datasets with rigorous bioinformatics support." This statement underscores the company's commitment to empowering global researchers across oncology, immunology, and neuroscience.

Supported by advanced microfluidics technologies, stringent quality control benchmarks, and tailored bioinformatics pipelines, Creative Biolabs continues to partner with academic and biopharmaceutical research teams worldwide to unravel the complexities of human disease. The implications of this expansion are far-reaching: by making single-cell and multi-omics analyses more accessible and reliable, Creative Biolabs is helping to drive the next wave of discoveries in biomedical research, ultimately contributing to improved diagnostics and therapies.